COVID-19 Epidemiology, Symptomatology, Mortality and Management in Early March 2020

This video describes Social Distancing, those affected by it, and tips for how to manage the stress.

First 27 references below

- Link for full paper

2. van Doremalen, N. et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N. Engl. J. Med. (2020) doi:10.1056/NEJMc2004973.
3. Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. (2020) doi:10.1016/S1473-3099(20)30120-1.
4. Zhu, N. et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
5. Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).
6. Ng, O.-T. et al. SARS-CoV-2 Infection among Travelers Returning from Wuhan, China. N. Engl. J. Med. (2020) doi:10.1056/NEJMc2003100.
7. Woelfel, R. et al. Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster. Infectious Diseases (except HIV/AIDS) (2020).
8. Zou, L. et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. New England Journal of Medicine vol. 382 1177–1179 (2020).
9. Dong, Y. et al. Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China. Pediatrics (2020) doi:10.1542/peds.2020-0702.
11. Mizumoto, K., Kagaya, K., Zarebski, A. & Chowell, G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 25, (2020).
12. Wang, C. et al. Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China. medRxiv 2020.03.03.20030593 (2020).
13. Klompas, M. Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible. Ann. Intern. Med. (2020) doi:10.7326/M20-0751.
15. Wu, Z. & McGoogan, J. M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA (2020) doi:10.1001/jama.2020.2648.
16. Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (2020) doi:10.1016/S0140-6736(20)30566-3.
17. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi 41, 145–151 (2020).
18. Baud, D. et al. Real estimates of mortality following COVID-19 infection. Lancet Infect. Dis. (2020) doi:10.1016/S1473-3099(20)30195-X.
19. Mizumoto, K. & Chowell, G. Estimating the risk of 2019 Novel Coronavirus death during the course of the outbreak in China, 2020. Infectious Diseases (except HIV/AIDS) (2020).
20. Imperial College COVID-19 Response Team, Ferguson, N. M., Laydon, D., Nedjati-Gilani, G. & al., E. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. (2020) doi:10.25561/77482 .
21. Lu, X. et al. SARS-CoV-2 Infection in Children. N. Engl. J. Med. (2020) doi:10.1056/NEJMc2005073.
24. Lan, L. et al. Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA (2020) doi:10.1001/jama.2020.2783.
25. Chen, Y. et al. Re-evaluation of Nucleic Acid Retested Positive Cases in the Recovered COVID-19 Patients: Report from a Designated Transfer Hospital in Chongqing, China. In Review (2020).